je.st
news
Home
› To sell or not to sell: United Therapeutics faces choice with potential fast-track drug voucher
To sell or not to sell: United Therapeutics faces choice with potential fast-track drug voucher
2015-03-18 21:42:25| Biotech - Topix.net
Martine Rothblatt is the CEO of United Therapeutics Corp., which recently received Food and Drug Administration approval for its drug, Unituxin for treating pediatric patients with high-risk neuroblastoma. It also received a voucher that can be used to fast track a drug through the FDA's regulatory process.
Tags: united
sell
potential
choice
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||